The cost of musculoskeletal care isn’t fixed. It’s determined — at the very first visit.
Musculoskeletal conditions are the largest or near-largest category of healthcare spend for most self-insured employers — and the most variable. Joint and Spine Solutions changes the trajectory by changing how the problem is assessed and managed from the start.
The problem is not just how much musculoskeletal care costs. It is how the care gets determined in the first place.
For most self-insured employers, musculoskeletal conditions are the largest or near-largest category of healthcare spend — and the cost climbs year over year. The clinical cost is the same on both sides of the ledger: the imaging, the specialist visits, the injections, the procedures, and the surgeries show up whether the problem runs through group health or workers’ compensation. So does the cost beyond the claim — lost productivity and time away from work follow an injury regardless of which bucket pays for it. Workers’ compensation adds its own layer on top: mod factors, claims administration, and the regulatory burden that comes with a work-related injury. Most employers experience all of this as rising spend they have quietly accepted as a fixed cost of doing business — simply how the system works. It is not. The year-over-year climb is not inevitable. It is the predictable result of how musculoskeletal care gets determined and managed, and when that changes, the trajectory changes.
The usual explanation is utilization — too much imaging, too many specialist visits, too many procedures. That is real, but it is a symptom. The driver sits earlier in the pathway, in how the musculoskeletal problem gets assessed and classified at the first visit. Get that determination right, and the downstream utilization takes care of itself. Get it wrong, and no amount of downstream management fully recovers.
You cannot manage what you do not measure.
Most organizations track musculoskeletal spend the way they track the weather: it goes up a little every year, and that climb — commonly eight to ten percent — gets treated as a fixed cost of doing business. What almost no one has been shown is that the spend has a quality to it. A musculoskeletal program can be high-value, low-value, or simply unremarkable — and which one you have is measurable. That is not a knock on any organization, including well-run and sophisticated ones. It is a category of insight the system was never built to surface, because the system is paid to deliver more care, not to tell you whether the care was right.
Start with the questions that actually reveal that quality. Of your employees who reported a back, neck, shoulder, or knee problem last year, what percentage ended up with an MRI? What percentage had an injection, or a pain-management procedure? What percentage had surgery? How many were still seeking care six months after they first reported the problem? How much short- and long-term disability did those cases generate? These are the numbers that tell you whether your musculoskeletal spend is buying good care — and most employers cannot answer them. Not because the data is hidden, but because no one has ever assembled it. The answers live in your claims data, and until someone goes and looks, the quality of the spend stays invisible.
Those numbers matter because there is a known difference between what a broken front end produces and what a reliable one produces. When musculoskeletal care runs through usual community care, roughly one in four cases ends up with an MRI. Run the same population through a reliable, quality-assured, data-enabled process, and that falls to about one in eight — half as many — almost exactly the reduction Donelson documented in the published claims data. Surgery is the starker one. Before a reliable front end is in place, surgical rates commonly run in the low-to-mid teens — say twelve to fifteen percent of musculoskeletal cases. Once it is, that rate drops sharply: Donelson documented a 78% reduction in surgery, which would take a fifteen percent rate down to roughly three percent. That is the gap — a system quietly sending one in seven people to surgery, versus one in thirty.
That gap is the value being left on the table, every year, invisibly — and it is worth being clear about why it happens, because it is not anyone acting in bad faith. Send a patient down the imaging pathway, and the cost and the odds of a procedure both go up. Send them to a surgeon, and they meet someone trained to fix things with surgery; send them to a pain-management physician, and they meet someone trained to manage pain with injections and procedures. Each clinician does what they are trained to do. The determination of which of them the patient should have seen in the first place — that is the decision no one is reliably making, and it is the decision that sets everything downstream.
This is the simplest test of any musculoskeletal program, including ours: a system worth trusting can tell you how it performs. From the moment JSS begins seeing your people, it reports in real time on the patients it treats — the conditions, the pain and function scores, the validated outcome measures, and patient satisfaction, which under a reliable mechanical-care process has consistently run above ninety-five percent. That is the live picture. The deeper utilization picture — the imaging, surgery, and injection rates across your whole population — comes from your claims data, and it is the before-and-after that shows what changed. A program willing to be measured on both has nothing to hide. A program that answers with a brochure instead of a number has told you something.
Knowing where you stand before you start is not a formality. It is how you find out whether the climb you have accepted as inevitable is actually inevitable — or whether you have simply never measured the thing that could change it. Not every engagement requires a full claims analysis; smaller organizations can begin more simply. But for an organization that wants the truth about where it has been, where it is now, and what changed, the claims data is the honest answer. Joint and Spine Solutions begins there — so the first thing you receive is not a promise, but a clear measure of what your current system has actually been producing.
Administrative fixes can’t solve a clinical problem.
Whether your musculoskeletal spend has been climbing or holding steady, the more important question is the same: is it buying good care? Almost every common fix aimed at that spend is an administrative lever applied on top of a clinical determination that was likely not made in a reliable way in the first place. A review, a network, an approval requirement, a second opinion — each one manages the paperwork around the decision without meaningfully changing the decision itself.
The second opinion is the clearest example. A second opinion that reviews the same image and the same notes the first clinician already had — rather than reliably reassessing the patient — arrives at a similar place, because a second look at the same information through the same pathology-and-imaging framework tends to reach the same conclusion. The problem was never that the review was done by the wrong person. It’s that the determination upstream of the review — what is actually driving this patient’s pain, and what should happen first — was made unreliably, and no amount of downstream review repairs a starting point that was off.
This is the difference a reliable front end makes, and it’s best shown by what it looks like in practice. At a large self-insured employer JSS works with, the arrangement is not a blanket hold on imaging or referrals — a hold is just another administrative lever, and it treats the patient who needs the scan exactly like the patient who doesn’t. Instead, patients are seen by Joint and Spine Solutions first, and the assessment does the determining. Mercifully, most musculoskeletal problems respond to conservative care — and for those patients, that is where it ends. For the ones who don’t respond, the same reliable assessment is what identifies the most appropriate next step: a surgical consult, a pain-management consult, or a return to their physician for medical workup. This is where reliable assessment proves itself twice over. It is not only better at resolving problems conservatively and keeping them resolved — it is better at identifying who genuinely needs to escalate, and to where, than a system that routes patients by whichever specialty they happened to land in first. The direction is set by how the problem actually behaves and responds, not by a clinician’s preference or the accident of the first door. When escalation is warranted, it happens promptly, and the receiving clinician at least knows the basics — this patient has been through a reliable conservative trial and is not responding. One approach delays the decision. The other one makes it.
And it’s worth being clear about what this produces. None of it was designed to save money. It was designed to give the best possible care to the person in front of us — and the best care, it turns out, is also the least costly. Because these patients are seen by Joint and Spine Solutions first, and assessed through an inter-examiner-reliable process that is quality-assured and data-enabled in real time, the majority get better with conservative care — so they never needed the image or the surgery in the first place. And the patient who genuinely does need more isn’t made to wait: the one who needs a surgical or pain-management consult gets it expeditiously, usually sooner than the default six-to-eight weeks of general conservative care would have allowed. One process, two right answers — because it determines what the problem actually is, instead of letting an image decide. That combination — better care at lower total cost — is the definition of health care value.
This isn’t theoretical. It was measured — in a company like yours.
Everything to this point describes how the model works. Here is what happened when someone measured it.
In a peer-reviewed analysis by Donelson and colleagues of a year of claims data at a large self-insured manufacturer — more than five thousand employees and dependents, risk-adjusted to compare like with like — the people whose musculoskeletal care ran through a reliable, quality-assured, data-enabled assessment cost 51% less per patient than the people who received usual community care. Same company, same kinds of people, the same problems. The difference was how the care was determined at the front end and how it was managed at every visit afterward — reliably assessed, quality-assured throughout, rather than left to vary.
And the numbers underneath that cost difference are the ones an employer feels directly. Short-term disability duration was cut in half — people back to work in half the time. At six months, the employees who went through usual care were four and a half times more likely to still be seeking care for the same problem: still in the system, still costing, still not better. The imaging and surgery reductions you saw earlier on this page are part of the same result — and now you can see they weren’t aspirational figures. They were measured, at scale, in real claims data.
This is the point where the cost case and the care case stop being separate things. The 51% wasn’t produced by spending less on people. It was produced by getting more of them genuinely better, faster — and by sending the ones who needed something else to the right place without months of delay first. Lower cost was the byproduct of better care, measured in a real population, in a peer-reviewed study.
Joint and Spine Solutions did not run that study — but the model it uses came directly out of the organization the study evaluated. JSS’s founder was a treating clinician in that work and served as a vice president of clinical development at the organization whose results the study measured. The methodology, the credentialing, and the quality-assurance process behind those numbers are the same elements JSS runs today. The full study and the broader evidence are laid out on the Evidence and Outcomes page.
Built around your covered population, and the data to prove it out.
The most effective arrangement is simple: the people you insure have direct access to Joint and Spine Solutions. Not just employees — the insured. A company covering a hundred employees may be carrying two or three hundred lives once families are counted, and a musculoskeletal problem in any of them is a cost and a person worth getting right. Some organizations scope it more narrowly — employees only, or a specific population — and that’s fine. The principle is that access should reach the lives you’re actually carrying risk on.
It also doesn’t matter which bucket the cost comes from. Whether a back problem happened lifting a shovel at work or a case of water at Costco over the weekend, the same reliable assessment resolves it, and Joint and Spine Solutions will see the patient either way. A work-related claim brings additional administrative parties and process that a group-health claim doesn’t, but the clinical determination is identical. The problem gets assessed and managed the same way, regardless of which ledger ends up paying for it.
Throughout, outcomes do more than get reported — they actively guide the care. Every patient’s progress is tracked against what the assessment predicted, and any case that isn’t moving the way it should is automatically flagged and brought to grand rounds: a structured, collegial review where experienced clinicians work the case through together. That review most often confirms the case is on track for what it is; sometimes it refines the diagnosis or adjusts the approach; and occasionally it surfaces that the patient needs a different kind of care entirely — at which point the referral happens without weeks lost. The flag is automatic and applied to every case, so nothing drifts quietly. Outcomes aren’t a report you read after the fact. They’re the instrument steering the care in real time.
The effect doesn’t end when the episode does. Musculoskeletal problems recur at high rates, and most care does nothing to change that — because when the problem comes back, people go back to whatever they did last time: another adjustment, another round of passive treatment, another referral. They were made recipients of care, not participants in it. This process works the other way. The patient is carried through to genuinely restored function and then taught two things most care never provides: why the problem happened, and how to catch the earliest sign of it returning — days before it becomes pain — and head it off themselves. A problem intercepted at home in its first days never becomes a visit, a claim, or a procedure. That is how recurrence actually comes down, and it is the difference between buying a cheaper episode of care and gaining an employee far less likely to generate the next one.
And for an organization that wants to know what all of this is actually doing, the answer is in the claims data. Not every engagement requires a full claims analysis — smaller organizations can start more simply. But for those who want the truth about where they’ve been, where they are, and what changed, a baseline drawn from their own claims is the honest measure. It’s the same report card this page opened with — now turned on your own population, before and after.
Better outcomes and lower cost are not a trade-off. They are what a reliable front end produces.
The year-over-year climb in musculoskeletal cost is not a fixed cost of doing business. It is the predictable result of an unreliable front end — variation in how the problem is assessed and heavy reliance on imaging, and the cascade of downstream decisions those two set in motion.
Change the front end, and the cascade never starts. When the people you insure are assessed first through a reliable, quality-assured, data-enabled process, most get better with conservative care — so they never needed the image or the surgery. The ones who genuinely need something more are identified quickly and sent to the right place without weeks lost. Nobody’s care is withheld; the right care is simply determined sooner and more reliably.
That is why you don’t have to choose between better care and lower cost — they come from the same thing. Because the assessment is inter-examiner reliable and quality-assured, it teases out the people who can truly get better conservatively, and gets the ones who can’t down the right pathway. The savings don’t come from withholding anything. They come from the fact that the people who didn’t need a surgery, an injection, or a specialist referral don’t get one — because they don’t need it. Nearly all of the cost in musculoskeletal care lives downstream, in the advanced imaging, the consults, the procedures, and the surgeries. Reduce the downstream care that was never needed, and the cost comes down with it.
And it is not theoretical. It was measured — a 51% lower per-patient cost in a real, risk-adjusted population — and it is reproducible, because it does not depend on a single gifted clinician. It rests on an inter-examiner-reliable examination process, delivered by clinicians trained and credentialed in it and held to it through quality assurance. That is the whole theme of this page in one line: musculoskeletal cost varies so wildly because the ways of assessing the problem vary so wildly — within professions and across them — and when you replace that variation with an assessment that is reliable from one clinician to the next, the outcomes get better and the cost comes down. Donelson demonstrated it in low back pain — the most expensive and most variable domain in all of musculoskeletal medicine, and the hardest place to do it. The only question left is what your own numbers would show. That is where a conversation begins
Find out what your musculoskeletal spend is actually buying.
If you are responsible for musculoskeletal cost, outcomes, or both — as an employer, a self-insured plan, or a partner organization — the first step is simply a conversation about your population, your costs, and what you are trying to solve. No preparation required. For organizations ready to go further, the next step is a baseline we build from three years of your claims data — showing exactly what the current system has been producing across your covered lives, before any decision about what to change. Joint and Spine Solutions works directly with the organizations that carry this cost, and would welcome the conversation.